Australia's largest stock trading and investment forum Australia's #1 stock forum

RGT

2.90%

35.5¢ argent biopharma limited

Varm Cosmo Delay, page-22

First 22 Last

Share
Profile

Follow
TheJuggernaut

667 Posts.

79

03/05/18

20:14

Post #: 32870617
Share

Originally posted by no vice ↑

Moving forward as we Trek, personally l don't think someone as astute or risk averse as Warren Buffet or his company Berkshire Hathaway would go anywhere near a company like MXC

As for the cosmetics arm, we can only hope that Derma cream is not priced at $400 Australian dollars equivalent in any foreign market because there simply won't be enough consumers that could afford to buy it. Supply and demand is definitely linked to astute pricing. I guess that's why Maybeleen walks off the shelf in Coles as their successful business model knows small margins and high volume caputes any market.

Far be it from me to pitch the marketing speel for MXC but you have to ask yourself at what point does a premium product over price itself. Let's face it, this is not rocket science. The plant grows proficiently and the world is populated by mostly poor people.

Logic would suggest to me that the big money spinner would be Cannepil fuelled by Government subsidies like the PBS scheme in this country, where exorbidant drug prices are ameliorated by the tax payer.

This would need to be backed by clinical research and peer reviewed literature, all of which takes a number of years. I would be surprised if the company generates any significant revenue this year or next year unless the Varm-Cosmo deal comes to something. This is based on my own clinical opinion and research through James Cook University.

Expand

Spot on

MXC Price at posting: 7.4¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

There are more pages in this discussion • 52 more messages in this thread...

First 22 Last

Add RGT (ASX) to my watchlist

(20min delay)
Last 35.5¢		Change 0.010(2.90%)		Mkt cap ! $17.18M

Open	High	Low	Value	Volume
35.0¢	36.0¢	34.5¢	$6.75K	18.84K

Buyers (Bids)

No.	Vol.	Price($)
1	1885	29.0¢

Sellers (Offers)

Price($)	Vol.	No.
36.5¢	100	1

View Market Depth

No.	Vol.	Price($)
1	1885	0.290
1	2200	0.230
1	20000	0.225
1	4545	0.220
2	6011	0.210

Price($)	Vol.	No.
0.365	100	1
0.380	79	1
0.400	1090	3
0.420	23	1
0.430	28	1

Last trade - 13.02pm 27/09/2024 (20 minute delay)

RGT (ASX) Chart

Varm Cosmo Delay, page-22

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

ACCC seeks Olam divestments before it can buy Namoi Cotton

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Varm Cosmo Delay, page-22

Top Stories

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

ACCC seeks Olam divestments before it can buy Namoi Cotton

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News